-
Something wrong with this record ?
Risk reduction and screening of cancer in hereditary breast-ovarian cancer syndromes: ESMO Clinical Practice Guideline
C. Sessa, J. Balmaña, SL. Bober, MJ. Cardoso, N. Colombo, G. Curigliano, SM. Domchek, DG. Evans, D. Fischerova, N. Harbeck, C. Kuhl, B. Lemley, E. Levy-Lahad, M. Lambertini, JA. Ledermann, S. Loibl, KA. Phillips, S. Paluch-Shimon, ESMO Guidelines...
Language English Country England, Great Britain
Document type Practice Guideline, Research Support, Non-U.S. Gov't
- MeSH
- Early Detection of Cancer MeSH
- Risk Reduction Behavior MeSH
- Neoplastic Syndromes, Hereditary * MeSH
- Genetic Predisposition to Disease MeSH
- Humans MeSH
- Breast Neoplasms * diagnosis genetics prevention & control MeSH
- Ovarian Neoplasms * diagnosis epidemiology genetics MeSH
- Check Tag
- Humans MeSH
- Female MeSH
- Publication type
- Research Support, Non-U.S. Gov't MeSH
- Practice Guideline MeSH
Basser Center for BRCA Abramson Cancer Center University of Pennsylvania Philadelphia USA
Champalimaud Foundation Breast Unit and Faculdade de Medicina Lisbon Portugal
Clinical Trials Project ESGO ENGAGe Prague Czech Republic
Department of Gynecologic Oncology Istituto Europeo di Oncologia e IRCCS Milan Italy
Department of Medicine and Surgery University of Milano Bicocca Milan Italy
Department of Oncology and Hemato Oncology University of Milano Milan Italy
Department of Oncology UCL Cancer Institute University College London and UCL Hospitals London UK
GBG Forschungs GmbH Neu Isenburg Germany
KIU Patient Organisation for Women with Gynaecological Cancer Copenhagen Denmark
Medical Oncology Oncology Institute of Southern Switzerland EOC Bellinzona Switzerland
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc23004797
- 003
- CZ-PrNML
- 005
- 20230425171727.0
- 007
- ta
- 008
- 230418s2023 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.annonc.2022.10.004 $2 doi
- 035 __
- $a (PubMed)36307055
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Sessa, C $u Medical Oncology, Oncology Institute of Southern Switzerland, EOC, Bellinzona, Switzerland
- 245 10
- $a Risk reduction and screening of cancer in hereditary breast-ovarian cancer syndromes: ESMO Clinical Practice Guideline / $c C. Sessa, J. Balmaña, SL. Bober, MJ. Cardoso, N. Colombo, G. Curigliano, SM. Domchek, DG. Evans, D. Fischerova, N. Harbeck, C. Kuhl, B. Lemley, E. Levy-Lahad, M. Lambertini, JA. Ledermann, S. Loibl, KA. Phillips, S. Paluch-Shimon, ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a časná detekce nádoru $7 D055088
- 650 12
- $a nádory prsu $x diagnóza $x genetika $x prevence a kontrola $7 D001943
- 650 12
- $a dědičné nádorové syndromy $7 D009386
- 650 12
- $a nádory vaječníků $x diagnóza $x epidemiologie $x genetika $7 D010051
- 650 _2
- $a chování snižující riziko $7 D040242
- 650 _2
- $a genetická predispozice k nemoci $7 D020022
- 655 _2
- $a směrnice pro lékařskou praxi $7 D017065
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Balmaña, J $u Medical Oncology Hospital Vall d'Hebron and Hereditary Cancer Genetics Group, Vall d'Hebron Institut of Oncology, Barcelona, Spain
- 700 1_
- $a Bober, S L $u Department of Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute/Harvard Medical School, Boston, USA
- 700 1_
- $a Cardoso, M J $u Champalimaud Foundation, Breast Unit and Faculdade de Medicina, Lisbon, Portugal
- 700 1_
- $a Colombo, N $u Department of Gynecologic Oncology, Istituto Europeo di Oncologia e IRCCS, Milan, Italy; Department of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy
- 700 1_
- $a Curigliano, G $u Early Drug Development for Innovative Therapies Division, Istituto Europeo di Oncologia, IRCCS, Milan, Italy; Department of Oncology and Hemato-Oncology, University of Milano, Milan, Italy
- 700 1_
- $a Domchek, S M $u Basser Center for BRCA, Abramson Cancer Center, University of Pennsylvania, Philadelphia, USA
- 700 1_
- $a Evans, D G $u Manchester Centre for Genomic Medicine, Division of Evolution Infection and Genomic Sciences, University of Manchester, MAHSC, Manchester, UK; Manchester Centre for Genomic Medicine, MAHSC, St Mary's Hospital, Manchester University Hospitals NHS Foundation Trust, Manchester, UK
- 700 1_
- $a Fischerova, D $u Gynecologic Oncology Center, Department of Obstetrics and Gynecology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic
- 700 1_
- $a Harbeck, N $u Breast Center, Department of Obstetrics & Gynecology and Comprehensive Cancer Center Munich, LMU University Hospital, Munich, Germany
- 700 1_
- $a Kuhl, C $u Department of Diagnostic and Interventional Radiology, University Hospital Aachen, University Hospital Aachen (UKA), RWTH Aachen, Germany
- 700 1_
- $a Lemley, B $u KIU - Patient Organisation for Women with Gynaecological Cancer, Copenhagen, Denmark; Clinical Trials Project, ESGO ENGAGe, Prague, Czech Republic
- 700 1_
- $a Levy-Lahad, E $u Medical Genetics Institute, Shaare Zedek Medical Center, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel
- 700 1_
- $a Lambertini, M $u Department of Internal Medicine and Medical Specialties (DiMI), School of Medicine, University of Genova, Genoa, Italy; Department of Medical Oncology, U.O. Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genoa, Italy
- 700 1_
- $a Ledermann, J A $u Department of Oncology, UCL Cancer Institute, University College London and UCL Hospitals, London, UK
- 700 1_
- $a Loibl, S $u GBG Forschungs GmbH, Neu-Isenburg, Germany
- 700 1_
- $a Phillips, K-A $u Department of Medical Oncology, Peter MacCallum Cancer Centre and The Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Australia
- 700 1_
- $a Paluch-Shimon, S $u Sharett Institute of Oncology Department, Hadassah University Hospital & Faculty of Medicine Hebrew University, Jerusalem, Israel
- 710 2_
- $a ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org
- 773 0_
- $w MED00000432 $t Annals of oncology : official journal of the European Society for Medical Oncology $x 1569-8041 $g Roč. 34, č. 1 (2023), s. 33-47
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/36307055 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20230418 $b ABA008
- 991 __
- $a 20230425171723 $b ABA008
- 999 __
- $a ok $b bmc $g 1925094 $s 1191006
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2023 $b 34 $c 1 $d 33-47 $e 20221025 $i 1569-8041 $m Annals of oncology $n Ann Oncol $x MED00000432
- LZP __
- $a Pubmed-20230418
